Leiomyosarcoma Metastatic

Metastatic leiomyosarcoma is an aggressive cancer that has spread from its original site to other parts of the body. While this advanced stage presents serious challenges, understanding the disease, treatment options, and survival factors can help patients and their families navigate this difficult journey.

Table of contents

• What is Metastatic Leiomyosarcoma?
• How Leiomyosarcoma Spreads
• Symptoms and Detection
• Diagnosis
• Treatment Approaches
• Survival and Prognosis

What is Metastatic Leiomyosarcoma?

Leiomyosarcoma is a rare, aggressive cancer that begins in smooth muscle tissue. Smooth muscles are involuntary muscles found in various parts of the body, including the bladder, blood vessels, large and small intestines, stomach, and uterus^[3]. When leiomyosarcoma is described as metastatic, it means the cancer has spread beyond its original location to other parts of the body.

This cancer is one of the most common subtypes of soft tissue sarcoma, accounting for 10% to 20% of all sarcoma cases^[1]. In the United States, about 1 in every 100,000 people develops leiomyosarcoma^[3]. The cancer grows quickly and can double in size in as little as one month^[3].

How Leiomyosarcoma Spreads

Leiomyosarcoma cancer cells travel through the bloodstream and can spread to almost any soft tissue in the body^[3]. While the cancer can appear almost anywhere, certain locations are more frequent sites for metastatic spread, which is when cancer moves from its original site to other body parts^[4].

The most common sites where leiomyosarcoma spreads include the lungs, liver, brain, and occasionally the bones^[4]. Understanding where the cancer has spread helps doctors determine the best treatment approach.

When leiomyosarcoma metastasizes, doctors must determine whether there are few or many metastatic sites. This assessment is crucial because it affects how the disease is treated. When there are only a few metastatic sites, the condition may still be treated as a local problem. However, when there are many sites of spread, doctors view the condition as systemic, meaning it affects the entire body rather than just one area^[4].

Symptoms and Detection

Some people don’t develop symptoms until leiomyosarcoma reaches an advanced stage, which makes early detection challenging^[3]. The symptoms vary depending on where the cancer is located and how large the tumor has grown.

General symptoms of leiomyosarcoma may include a firm, painless lump, abdominal bloating, fever, nausea and vomiting, pain, tiredness, and weight loss^[3][11]. When the cancer affects the digestive system, it may cause abdominal pain, black stools from blood in the stool, loss of appetite, and nausea and vomiting^[3].

For uterine leiomyosarcoma, symptoms can include abnormal uterine bleeding, frequent urination, and vaginal discharge^[3]. It’s important to note that leiomyosarcoma often doesn’t cause signs or symptoms at first, and symptoms only appear as the cancer grows^[2].

Diagnosis

Diagnosing metastatic leiomyosarcoma requires several steps. A healthcare provider will perform a physical examination, ask about symptoms, and review the patient’s medical history, including any past or current health conditions^[3].

Imaging tests are essential to see inside the body and determine the size and location of tumors. These tests may include angiography (an imaging technique that examines blood vessels), computed tomography (CT) scans (which create detailed cross-sectional images of the body), magnetic resonance imaging (MRI) (which uses magnets and radio waves to create detailed images), and PET scans (which show how organs and tissues are functioning)^[3].

A biopsy, which involves taking a small sample of tissue for examination under a microscope, is typically required for diagnosis^[1][3]. This helps doctors confirm whether cancerous cells are present and determine the specific type of cancer.

Treatment Approaches

Treating metastatic leiomyosarcoma is complex and often requires an interdisciplinary approach involving multiple specialists^[1]. The treatment strategy depends on how far the cancer has spread and where the metastatic sites are located.

Surgery

When there are only a few metastatic sites, surgical removal of the tumors is the most common approach^[4]. Surgery is considered the cornerstone of curative therapy for leiomyosarcoma^[1]. Surgeons aim to remove tumors using wide margins, which means removing extra healthy tissue around the tumor to ensure all cancer cells are eliminated^[4].

The expertise of the surgeon is crucial. Generally, patients are referred to experienced oncological surgeons rather than general surgeons because the work is more complex^[4]. A patient’s ultimate prognosis is often determined by the surgeon who performs the initial removal of the tumor^[4].

Chemotherapy

When there are many metastatic sites, chemotherapy becomes the preferred approach because the condition is viewed as systemic^[4]. However, it’s important to understand that leiomyosarcoma is often resistant to radiation or chemotherapy, and surgical removal or local ablative methods (techniques that destroy tumor tissue) such as cryosurgery, embolization, and hyperthermia are often more effective^[4].

For metastatic and unresectable leiomyosarcoma, first-line chemotherapy typically includes anthracycline-based regimens or gemcitabine-based regimens, which provide a median progression-free survival time of about 5 months and overall survival time between 14 and 16 months^[7].

Common chemotherapy drugs used for leiomyosarcoma include doxorubicin, ifosfamide, gemcitabine, docetaxel (also known as Taxotere), dacarbazine, and ecteinascidin^[10]. A recent clinical trial showed that adding trabectedin (Yondelis) to doxorubicin as an initial treatment helped people with advanced leiomyosarcoma live longer than those treated with doxorubicin alone: a median of 33 months versus 24 months^[8].

It’s important to note that chemotherapy alone is not considered an effective means of eliminating leiomyosarcoma. Surgery, typically with a wide surgical margin to prevent local recurrence, is the only form of treatment with substantial results^[10].

Radiation Therapy

Radiation and chemotherapy serve as important adjuncts to surgery^[1]. Radiation therapy may be recommended in certain cases, particularly when surgery is not possible or to treat remaining cancer cells after surgery.

Other Treatment Options

If surgery is not an option for a few metastatic sites, ablation followed by chemotherapy or radiation therapies is the standard approach^[4]. There are also advances in new treatments, including targeted agents and immunotherapy, which have the potential to improve patient outcomes^[1].

Molecular therapies are also being explored for metastatic leiomyosarcoma. The most promising approaches include targeting DNA damage repair pathways and aberrant metabolism associated with cancer development, as well as novel chemotherapy combinations^[7].

Survival and Prognosis

Prognosis for metastatic leiomyosarcoma is related to several factors, including the tumor’s location, size, and grade. The tumor grade significantly impacts overall survival, and with higher-grade lesions, the rate of distant metastasis increases^[1].

In general, doctors give those with leiomyosarcoma a five-year survival window. The survival rates break down approximately as follows: for localized tumors (caught early before spreading), there’s a 63% survival rate; for regional spread (within the area where it originated), a 36% survival rate; and for distant spread (to other parts of the body), a 14% survival rate^[19].

A study from MD Anderson Cancer Center found that for patients with metastatic leiomyosarcoma, median overall survival times varied depending on several factors^[5]. These survival rates emphasize the importance of early detection and aggressive treatment.

The outlook is more favorable when the disease is detected and treated early^[3]. However, some patients don’t develop symptoms until the disease reaches an advanced stage, which makes leiomyosarcoma life-threatening in these cases. Recovery is possible, especially with early detection^[3].

Treatment at high-volume sarcoma centers is preferred and improves patient outcomes^[1]. Seeking care from specialists who have experience with this rare cancer can make a significant difference in treatment success.

Long-term survivors of metastatic leiomyosarcoma do exist. These “thrivers” often emphasize the importance of aggressive treatment, close work with treatment teams, and extensive research about the disease^[14]. Staying fit to help chemotherapy fight the cancer has also been noted as important by long-term survivors^[14].